By Professor Michael John Rogers

Conference Papers

Rogers MJ; Junankar S; McKenna CE; Sun S; Tri GP, 2014, 'Intravital 2-photon imaging reveals tumour-associated macrophages as the cellular targets underlying the anti-tumour activity of bisphosphonates in vivo.', in JOURNAL OF BONE AND MINERAL RESEARCH, WILEY-BLACKWELL, TX, Houston, pp. S14 - S14, presented at Annual Meeting of the American-Society-for-Bone-and-Mineral-Research, TX, Houston, 12 September 2014 - 15 September 2014, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000356598700039&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Wuerger T; Roschger P; Zwettler E; Fratzl P; Rogers MJ; Klaushofer K; Rumpler M, 2012, 'Osteoclasts on bone and dentin in vitro: Mechanism of degradation and comparison of resorption behaviour', in BONE, ELSEVIER SCIENCE INC, AUSTRIA, Vienna, pp. S9 - S9, presented at International Conference on Progress in Bone and Mineral Research / Annual Autumn Conference of the Austrian-Society-for-Bone-and-Mineral-Research including a Symposium on Calcium Sensing Receptor, AUSTRIA, Vienna, 29 November 2012 - 01 December 2012, http://dx.doi.org/10.1016/j.bone.2012.08.023

Sun S; Blazewska KM; Kashemirov BA; Roelofs AJ; Coxon FP; Rogers MJ; Ebetino FH; Mckenna MJ; Mckenna CE, 2011, 'Synthesis and characterization of novel fluorescent nitrogen-containing bisphosphonate imaging probes for bone active drugs', in Phosphorus Sulfur and Silicon and the Related Elements, pp. 970 - 971, http://dx.doi.org/10.1080/10426507.2010.526674

Shay G; Hornick M; Heys S; Weilbaecher K; Rogers M, 2011, 'Abstract LB-159: Bisphosphonates are internalised by myeloid derived suppressor cells (MDSCs) in vivo in a mouse model of breast cancer', in Cancer Research, American Association for Cancer Research (AACR), http://dx.doi.org/10.1158/1538-7445.am2011-lb-159

Thompson K; Roelofs AJ; Jauhiainen M; Mönkkönen H; Mönkkönen J; Rogers MJ, 2010, 'Activation of γΔ T cells by bisphosphonates', in Advances in Experimental Medicine and Biology, pp. 11 - 20, http://dx.doi.org/10.1007/978-1-4419-1050-9_2

Russell RGG; Xia Z; Dunford JE; Oppermann U; Kwaasi A; Hulley PA; Kavanagh KL; Triffitt JT; Lundy MW; Phipps RJ; Barnett BL; Coxon FP; Rogers MJ; Watts NB; Ebetino FH, 2007, 'Bisphosphonates: An update on mechanisms of action and how these relate to clinical efficacy', in Annals of the New York Academy of Sciences, pp. 209 - 257, http://dx.doi.org/10.1196/annals.1402.089

Thompson K; Rogers MJ, 2006, 'Alkylamines and bisphosphonates: A common mechanism for activation of γδ T-cells', in Haematologica Reports, pp. 1 - 3

Rogers MJ, 2006, 'New insights into the molecular actions of nitrogen-containing bisphosphonates', in Haematologica Reports, pp. 24 - 25

Lipton A; Berenson JR; Body JJ; Boyce BF; Bruland OS; Carducci MA; Cleeland CS; Clohisy DR; Coleman RE; Cook RJ; Guise TA; Pearse RN; Powles TJ; Rogers MJ; Roodman GD; Smith MR; Suva LJ; Vessella RL; Weilbaecher KN; King L, 2006, 'Advances in treating metastatic bone cancer: Summary statement for the First Cambridge Conference', in Clinical Cancer Research, http://dx.doi.org/10.1158/1078-0432.CCR-06-1213

Ebetino FH; Rozé CN; McKenna CE; Barnett BL; Dunford JE; Russell RGG; Mieling GE; Rogers MJ, 2005, 'Molecular interactions of nitrogen-containing bisphosphonates within farnesyl diphosphate synthase', in Journal of Organometallic Chemistry, pp. 2679 - 2687, http://dx.doi.org/10.1016/j.jorganchem.2005.03.005

Shipman CM; Rogers MJ; Vanderkerken K; Van Camp B; Russell RGG; Croucher PI, 2000, 'Bisphosphonates: Mechanisms of action in multiple myeloma', in Acta Oncologica, pp. 829 - 835, http://dx.doi.org/10.1080/028418600750063587

Rogers MJ; Gordon S; Benford HL; Coxon FP; Luckman SP; Monkkonen J; Frith JC, 2000, 'Cellular and molecular mechanisms of action of bisphosphonates', in Cancer, pp. 2961 - 2978, http://dx.doi.org/10.1002/1097-0142(20000615)88:12+<2961::aid-cncr12>3.0.co;2-l

Russell RGG; Croucher PI; Rogers MJ, 1999, 'Bisphosphonates: Pharmacology, mechanisms of action and clinical uses', in Osteoporosis International, pp. S66 - S80, http://dx.doi.org/10.1007/PL00004164

Russell RGG; Rogers MJ; Frith JC; Luckman SP; Coxon FP; Benford HL; Croucher PI; Shipman C; Fleisch HA, 1999, 'The pharmacology of bisphosphonates and new insights into their mechanisms of action', in Journal of Bone and Mineral Research, pp. 53 - 65, http://dx.doi.org/10.1002/jbmr.5650140212

Rogers MJ; Watts DJ; Russell RGG, 1997, 'Overview of bisphosphonates', in Cancer, pp. 1652 - 1660, http://dx.doi.org/10.1002/(sici)1097-0142(19971015)80:8+<1652::aid-cncr15>3.0.co;2-z

Kiernan BW; Fleming J; Rogers MJC; Self TJ; Varela A; Paige AJW; Brown SDM; Steel KP, 1997, 'Analysis of the deaf mouse mutant, whirler', in British Journal of Audiology, pp. 84 - 85

Fleming J; Rogers MJC; Paige A; Varela A; Hughes DC; Ward M; Brown SDM; Steel KP, 1996, 'Progress in the identification of the whirler mutation', in British Journal of Audiology, pp. 139

Back to profile page